ADVDD01

Description

With managed ventricular pacing (MVP™) to pace less

Adapta™ DR is the first pacemaker with managed ventricular pacing (MVP™) technology, which reduces unnecessary right ventricular pacing by 99%.¹ Reducing unnecessary ventricular pacing has been shown to improve clinical outcomes by reducing the risks of atrial fibrillation (AF)^2–5 and heart failure hospitalization (HFH).^2,5

Gillis A, Pürerfellner H, Israel C, et al. Reduction of unnecessary ventricular pacing due to the managed ventricular pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease (SND) and AV block (AVB) indications. Presented at HRS 2005 (Abstract AB21-1).
Anderson HR, et al. Lancet. 1997;350:1210–1216.
Skanes AC, et al.  J Am Coll Cardiol. 2001;38:167–172.
Neilsen J, et al.  J Am Coll Cardiol. 2003;42:614–623.
Sweeney M, et al. Circulation. 2003;107:2932–2937.

Not what you're looking for?

Find more information, including other available configurations, for Adapta™ pacemaker.

First Name

Last Name

Hospital Or Organization

Job Role

Specialty

Confirm country/region

Just to confirm, is this the product or product type that interests you?

{{productNamePlaceholder}}

Confirm country/region

Before we get started, what best describes you?

Confirm country/region

Before we get started, what best describes you?

First Name

Last Name

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

PHONE

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

Description

With managed ventricular pacing (MVP™) to pace less

Not what you're looking for?

United States

Customer Care Team